A Simple and Reliable Protocol for the Preparation and Culturing of Fresh Surgically Resected Human Glioblastoma Tissue.
brain tumour
cell culture
glioblastoma
glioma
primary cell culture
tissue culture
Journal
Methods and protocols
ISSN: 2409-9279
Titre abrégé: Methods Protoc
Pays: Switzerland
ID NLM: 101720073
Informations de publication
Date de publication:
22 Jan 2020
22 Jan 2020
Historique:
received:
08
12
2019
revised:
12
01
2020
accepted:
21
01
2020
entrez:
26
1
2020
pubmed:
26
1
2020
medline:
26
1
2020
Statut:
epublish
Résumé
Glioblastoma is a heterogeneous glial cell malignancy with extremely high morbidity and mortality. Current treatment is limited and provide minimal therapeutic efficacy. Previous studies were reliant on cell lines that do not accurately reflect the heterogeneity of the glioma microenvironment. Developing reliable models of human glioblastoma is therefore essential. Direct culture of human brain tumours is often difficult and there is a limited number of protocols available. Hence, we have developed an effective method for the primary culture of human glioblastoma samples obtained during surgical resection. Culturing tumour tissue direct from human brain is advantageous in that cultures (1) more closely resemble true human disease, relative to the use of cell lines; (2) comprise a range of cellular components present in the natural tumour microenvironment; and (3) are free of added antibodies and reagents. Additionally, primary glioblastoma cultures are valuable in studies examining the effects of anti-cancer pharmaceuticals and therapeutic agents, and can be further used in live cell imaging, immunocytochemistry, flow cytometry and immunoassay experiments. Via this protocol, cells are maintained in supplemented medium at 37 °C (5% CO
Identifiants
pubmed: 31979088
pii: mps3010011
doi: 10.3390/mps3010011
pmc: PMC7189671
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Brain Foundation Australia
ID : Mastura Monif - Brain Foundation 2018 Investigator grant
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
Clin Cancer Res. 2011 Jul 1;17(13):4296-308
pubmed: 21478334
Cancer Cell. 2017 Mar 13;31(3):326-341
pubmed: 28292436
Mol Cancer Res. 2008 Jan;6(1):21-30
pubmed: 18184972
Acta Neuropathol. 2017 Feb;133(2):263-282
pubmed: 28074274
Cent Eur J Immunol. 2014;39(2):209-15
pubmed: 26155126
Cancer Cell. 2006 May;9(5):391-403
pubmed: 16697959
J Neuroimmunol. 2019 Jul 15;332:138-146
pubmed: 31031209
Blood. 2011 Apr 28;117(17):4511-8
pubmed: 21389319
Front Immunol. 2017 Oct 26;8:1349
pubmed: 29123517
Asian Pac J Cancer Prev. ;18(1):3-9
pubmed: 28239999
Brain Behav Immun. 2016 Mar;53:1-15
pubmed: 26216710
Cancer Lett. 2017 Aug 28;402:93-99
pubmed: 28536012
Nat Commun. 2018 Dec 19;9(1):5379
pubmed: 30568188
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199